Meeting
2014 Gastrointestinal Cancers Symposium
Targeted analysis of progressive metabolic perturbations in colorectal cancer in colorectal adenoma: Potential for a serum metabolomics-based colorectal cancer screening test.
Authors
Farshad Farshidfar
Department of Surgery and Oncology, Faculty of Medicine, University of Calgary, Calgary, AB, Canada
Farshad Farshidfar , Aalim Weljie , Karen A. Kopciuk , Hans J. Vogel , Robert Hilsden , Elizabeth McGregor , Oliver F. Bathe
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
General Poster Session C: Cancers of the Colon and Rectum
Track
Cancers of the Colon, Rectum, and Anus
Sub Track
Prevention, Diagnosis, and Screening
Citation
J Clin Oncol 32, 2014 (suppl 3; abstr 426)
DOI
10.1200/jco.2014.32.3_suppl.426
Abstract #
426
Poster Bd #
A45
Abstract Disclosures
Similar Posters
Poster
2024 ASCO Gastrointestinal Cancers Symposium
Prospective study of a multi-modal blood-based test for colorectal cancer screening.
First Author: Paloma Peinado
Poster
2022 ASCO Annual Meeting
Characterization of time to diagnosis indicates shorter interval for screenable versus symptom-driven cancers.
First Author: Vladimir Gainullin
Poster
2024 ASCO Gastrointestinal Cancers Symposium
Circulating tumor DNA (ctDNA) positivity and its association with clinicopathological characteristics by novel blood-based test for colorectal cancer (CRC) screening from a multi-center large cohort: COSMOS-CRC-01.
First Author: Tatsuro Murano
Poster
2023 ASCO Breakthrough
The challenge of colorectal cancer (CRC) screening in low and middle-income countries (LMIC): The Brazilian ten year long experience.
First Author: Victor Filogonio